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Summary: Estradiol and human chorionic gonadotropin
(hCG) are very important in controlling the secretory activity of
hormone producing cells in the female rat pituitary glands.
The aim of the present study was to examine the morphomet -
ric parameters of immunohistochemically la be led ACTH cells
in juvenile (16th day) female rat pituitaries after treatment with
five doses of estradiol dipropionate (EDP) and two doses of
hCG during the neonatal period of life. The controls were
treated on the same schedule with an equivalent volume of
vehicle. All animals were sacrificed 24 h after the last treat-
ment. ACTH-producing cells were stu died using the peroxi-
dase-antiperoxidase immunohistochemical procedure. The
absolute and relative pituitary weights were increased
(p<0.05) only in the EDP treated group by 120.0% and by
121.1% respectively, in comparison with the controls. In this
group, the volume of ACTH cells, volume of their nuclei and
vo lume density were significantly decreased (p<0.05) by
6.4%, 33.3% and 46.2% respectively, compared to the corre-
sponding controls. After treatment with hCG, there were no
significant (p>0.05) changes neither in the volume of ACTH
cells nor in the volume of their nuclei, in comparison with the
controls. On the basis of the results obtained in our study, it
can be concluded that EDP, injected into female rats during the
neonatal period of life, has an inhibitory effect on the immu -
nohistomorphometric parameters of ACTH cells, but such an
effect is not clearly expressed after treatment with hCG.
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Kratak sadr`aj: Estradiol i humani horionski gonado -
tropin (hCG) veoma su va`ni u kontroli sekretorne aktivno -
sti }elija hipofize koje proizvode hormone. Cilj ove studije je
bio ispitati morfometrijske parametre imunohistohemijski
obele`enih ACTH }elija hipofize `enki pacova, u juvenil-
nom periodu (16. dan), nakon tretmana sa pet doza estra-
diol-dipropionata (EDP) ili dve doze humanog horionskog
gonadotropina (hCG). Kontrole su bile tretirane na isto -
vetan na~in sa odgovaraju}om koli~inom rastvara~a. Sve
`ivotinje su bile `rtvovane 24 h nakon poslednjeg tretmana.
ACTH }elije su bile imunohistohemijski obele`ene meto -
dom peroksidaza-antiperoksidaza (PAP). Dobijeni rezultati
ukazuju na zna~ajno pove}anje (p<0,05) apsolutne i rela-
tivne mase hipofize za 120% i 121,1% kod `enki tretiranih
sa EDP u odnosu na kontrolu. U ovoj grupi `enki pacova
volumen ACTH }elija i njihovih jedara, kao i njihova volu-
menska gustina su bili zna~ajno smanjeni (p<0,05) za
6,4%, 33,3% i 46,2% u pore|enju sa kontrolom. Nakon
tretmana hCG-om, volumen ACTH }elija, kao i volumen
njihovih jedara, nisu bili zna~ajno (p>0,05) promenjeni u
odnosu na kontrolu. Na osnovu dobijenih rezultata mo -
`emo zaklju~iti da EDP, injeciran `enkama pacova tokom
neonatalnog perioda `ivota, ima inhibitorni efekat na
imuno histomorfometrijske parametre ACTH }e lija, {to nije
tako jasno izra`eno nakon tretmana hCG-om.
Klju~ne re~i: ACTH }elije, EDP, hCG, `enke pacova
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Introduction
The hypothalamic-pituitary-adrenal (HPA) axis
represents an essential stress response system and a
dynamic interface for multiple physiological systems.
Biochemically interconnected, it generates rhythmic
hormone secretion. The respective hormones, cor ti -
co tropin-releasing hormone (CRH), adrenocortico -
tropic hormone (ACTH) and principle glucocortico -
steroids (CORT; i.e. cortisol in humans, corti co sterone
in rats) modulate their own secretion through feedfor-
ward and feedback mechanisms within the HPA axis
and exert physiological effects in target organs out-
side the HPA axis (1). Corticotrophs (ACTH cells) are
basophilic cells, which produce proopiomelanocortin
(POMC) and its derivatives including ACTH, melano -
tropin (MSH) and lipotropin (LPH). These cells repre-
sent approximately 15% to 20% of adenohypop hy sial
cells (2). ACTH release from the anterior pituitary is
regulated by a variety of hormones and neuropep-
tides, through both cAMP-dependent and cAMP-in -
dependent mechanisms (3, 4). 
It was shown that estrogen treatment decreases
the level of POMC mRNA and lowers the ACTH
response in stress-stimulated ovariectomized adult
female rats (5). In contrast, estradiol treatment
increased the ACTH level in middle-aged female rats
(6). Schreihofer et al. (7) report that the estrogen
receptor b (ER b) level is very low in rodent pituitaries,
while, unlike follicle-stimulating hormone (FSH),
luteinizing hormone (LH) and prolactin (PRL) cells,
less than 5% of ACTH cells express estrogen receptor
a (ERa) in the human pituitary (8). Considering the
low proportion of ER, it seems that the indirect mech-
anisms of estradiol action are considerable in ACTH
cells.
Placental human chorionic gonadotropin (hCG)
is a crucial hormone during pregnancy, maintaining
the corpus luteum during early gestation. It is a het-
erodimeric glycoprotein, composed of 244 amino
acids, with two subunits: a (alpha), identical to that of
LH, FSH and thyroid-stimulating hormone (TSH); and
b (beta), responsible for hormone-specific biological
functions (9). Human chorionic gonadotropin inter-
acts with the luteinizing hormone/choriogonado -
tropin (LHCG) receptor and promotes the mainte-
nance of the corpus luteum during the beginning of
pregnancy, causing it to secrete the hormone proges-
terone (10). Also, it was observed that hCG signifi -
cantly increases the number of pituitary FSH, LH and
TSH cells (11, 12).
The present study was focused on the histologi-
cal and morphometric characteristics of immunoposi-
tive ACTH cells of juvenile female rats, neonatally
treated with multiple doses of estradiol or with two
doses of hCG. 
Material and Methods
Wistar female rats, bred at the Institute for
Biological Research, Belgrade, Serbia, were used in
the experiment. The animals were kept under a
12:12 h light-dark cycle, at 22±2 °C. They had free
access to food (a product of the Veterinary Institute
Subotica, Subotica, Serbia) and water. Females were
divided into three groups of five animals. The first
group (EDP) received five intraperitoneal (i.p.) injec-
tions of estradiol dipropionate (EDP; 0.25 mg/kg
b.w., ICN Galenika Pharmaceuticals, Belgrade,
Serbia) every second day from the 4th to the 14th day
after birth. After the treatment with EDP, the animals
were sacrificed at the juvenile stage, when they were
17 days old. The second group of females (hCG) i.p.
received two doses of pregnyl-gonadotrophinum
chorionicum (hCG; 50 IU/kg b.w.; N.V. Oregon,
Netherlands) on the 15th and 16th day of life. The
control group was injected with an equivalent volume
of the vehicle. All animals were sacrificed 24 h after
the last treatment.
Pituitary glands were excised, weighed, fixed in
Bouin’s solution for 48 h and embedded in paraplast.
The relative pituitary weights were calculated from
the ratio of the measured pituitary weight and the
body weight for each animal. 
The experimental protocols were approved by
the Animal Care Committee of the Institute for Bio -
logical Research (Belgrade, Serbia) in conformity with
the recommendation provided in the European Con -
vention for the Protection of Vertebrate Animals Used
for Experimental and Other Scientific Purposes (ETS
No. 123, Appendix A). 
Immunohistochemical studies 
ACTH-producing cells were identified by immu -
no histochemistry using the peroxidase-antiperoxidase
method (PAP), described by Sternberger et al. (13).
Endogenous peroxidase activity was first blocked by
incubation with 0.3% hydrogen peroxide in methanol
for 15 min. Reduction of non-specific background
staining was achieved by incubation with normal por -
cine serum (DAKO A/S, Glostrup, Denmark), diluted
in phosphate-buffered saline pH 7.4 (PBS; 1:10), for
45 min. Sections were then overlaid with commer -
cially diluted primary antibodies (hACTH antiserum
DAKO A/S, Glostrup, Denmark) for 24 h at 4 °C. This
antibody strongly cross-reacts with rat ACTH (Star -
~evi} et al. (14); verified by Dr B. A. Yang of Dako
Corp.). After washing in PBS for 5 min, sections were
incubated for 60 min with a second antibody, swine
anti-rabbit IgG (DAKO, Glostrup, Denmark; diluted
1:100 in PBS), rinsed again in PBS for 5 min and
then incubated with rabbit PAP complex (DAKO A/S,
Glostrup, Denmark; diluted 1:100 in PBS), for 45
min. Binding sites were visualized using 0.05% dia -
minobenzidine (DAB; Serva, Heidelberg, Germa ny)
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and 0.03% hydrogen peroxide in 0.2 mol/L TRIS-HCl
buffer, pH 7.4. The sections were counterstained with
hematoxylin and mounted in Canada balsam (Molar
Chemicals KFT, Budapest, Hungary). For the control
sections, the primary antibody was omitted and re -
placed by PBS, pH 7.4.
Morphometry
Rat pituitaries were serially cut to 5 mm thick
sections. Two sections from the dorsal, three from the
middle and two from the ventral part (seven sections,
20 mm apart in total) of the rat pituitary glands were
analyzed. The point counting method was used at an
overall magnification of x1000 (15). The M42 multi-
purpose test grid, inserted into the ocular of a Zeiss
light microscope (Jena, Germany), was randomly
positioned on the pituitary section at the beginning of
counting. Counting was carried out on the following
50 test fields per section. Average values were calcu-
lated per pituitary i.e. per animal (7 sections, 350 test
fields) and five pituitaries were analyzed per group.
Cell volume (Vc; mm3), volume of the nuclei (Vn;
mm3) and volume density (percentage of immunore-
active cells in mm3, Vvc; %) were determined for
ACTH-immunoreactive cells. 
The following parameters were counted:
Pn – number of points hitting on the nuclei of
immunohistochemically labelled cells inside the test
field
Ptc – number of points hitting on the cytoplasm
of immunohistochemically labelled cells inside the
test field
Nn – number of the immunohistochemically
labelled cell nuclei inside the test field. 
The formula for calculating the nuclei volume
was: 
Vn = VVn/NV, 
and that for the cell volume calculation was:
Vc = 1/NV, where
VVn is – the volume density of ACTH cell nuclei
and Nv – the numerical density of ACTH cells. Nuclei
volume density (VVn) provides information about nu -
clei attendance in the estimated cells and is calcu -
lated as follows: 
VVn =SPn/SPtc.
Since rat ACTH cells are mononuclear, Nv cor-
responds to the number of cells per cubic millimeter,
according to the formula: 
Nv = (k/b) (Na3/2/VVn½).
On the basis of earlier karyometric studies (16),
the shape coefficient b for pituitary cells was estimat-
ed to be 1.382, k is a factor related to cell distribution
according to their size (in the case of ACTH cells its
value is 1) and NA is the number of cells in the plane
of the pituitary tissue section. Na is calculated as fol-
lows: 
NA = SNn/SPtc · a,
where a represents the rhombic area belonging
every point of the test system and is calculated using
the formula: 
a = d2 3 1/2/2, where
d is – the test line length in the test system
employed.
Volume density (VVC) is calculated as the ratio of
the sum of Pn and Ptc (Pn+Ptc) and the total number
of points in the test system. Since the test system with
42 points was used and parameters were calculated
using 50 test fields, the definite formula was:
VVC = (Pn+Ptc)/ 50 · 42.
Statistical analysis
STATISTICA® version 5.0 (StatSoft, Inc) was
used for all statistical analyses. Morphometric data
obtained for the experimental groups were subjected
to one-way analyses of variance (ANOVA). Duncan’s
multiple range test (Pharmacological Calculation
System, 1986) was used for post hoc comparisons
between groups. A confidence level of p<0.05 was
considered statistically significant. The data are pre-
sented as means ± SD.
Results and Discussion 
The data summarizing body weights, absolute
and relative pituitary weights of the female rats, treat-
ed with EDP or hCG, are presented in Figure 1A-C.
Body weights in the EDP-treated group were not sig-
nificantly different (p>0.05) compared to the corre-
sponding controls, which was also observed in our
earlier study, after estrogen treatment of rats during
the neonatal period (17). hCG had no effects on the
body weights in this study, and this is in accordance
with Lijesen et al. (18) who reported that there is no
scientific evidence for hCG efficacy in the treatment
of obesity. Absolute pituitary weight was significantly
increased (p<0.05) only in the EDP-treated animals
by 120.0%, in comparison with the controls (Figure
1B). Relative pituitary weight was significantly in crea -
sed (p<0.05) in the EDP-treated females by 121.1%,
compared to the controls (Figure 1C). In middle-aged
fe males, chronic EDP treatment was shown to in -
crease absolute pituitary weight (5). Lov ren et al. (10)
and Sekuli} et al. (12) have reported that EDP appli-
cation, in the critical neonatal period, has stimulatory
effects on the absolute pituitary weight and glycopro-
tein-producing cells morphometric parameters. Also,
it was demonstrated that EDP treatment increases the
J Med Biochem 2012; 31 (1) 37
number of chromophobes, PRL (19, 20) and LH cells
(11), which confirms our results.
ACTH cells were positioned throughout the pitu-
itary pars distalis and pars intermedia. The character-
istic findings for the immunohistochemically labeled
ACTH cells in control juvenile females considered
their stellate shape with cytoplasmatic processes
among neighboring (mostly somatotrophic) cells, and
the cell localization between capillaries. The nuclei
were often centrally located (Figure 2A). In females
treated with EDP, neither the shape nor the localiza-
tion of ACTH immunopositive cells were altered com-
Figure 1. Body weight (g); B. absolute pi tuitary weight
(mg); C. relative pituitary weight (mg%): in control, estradiol
dipropionate (EDP) and human chorionic gonadotropin
(hCG) treated female rats. All values are means ± standard
deviation, n = 5 animals per group, *p<0.05 vs. control.
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Figure 2. Immunopositive ACTH cells in the pars distalis of
the pituitary gland from a control female rat; B. small ACTH
cells, with intensely immunostained cytoplasm, in an estra-
diol dipropionate (EDP) treated female rat; C. less immuno -
stained ACTH cells in a human chorionic gona dotropin
(hCG) treated female rat. PAP, bar = 16 mm
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pared to the controls. These cells were smaller in size,
with intensely immunostained cytoplasm (Figure 2B).
Kosti} et al. (6) previously demonstrated that after
EDP treatment, ACTH cells in middle-aged female
rats do not change their immunohistochemical
appearance. In animals treated with hCG the shape
and localization of ACTH cells were not changed, but
the cytoplasm was less intensely immunostained than
in the corresponding controls (Figure 2C). 
Different studies have established a positive cor-
relation between the morphological changes of ACTH
cells and their functional state. The morphometric
parameters measured in the present study, i.e. the vo -
lume of ACTH cells and the volume of their nuclei, as
well as volume density are depicted in Figure 3A-C. In
animals treated with EDP, the ACTH cell volume, vo l -
ume of their nuclei and the volume density were sig-
nificantly decreased (p<0.05) by 6.4%, 33.3% and
46.2% respectively, in comparison with the correspond -
ing controls. It was reported that estrogen replace-
ment lowers the POMC mRNA level and the ACTH
response in ovariectomized rats (5), but some studies
suggest the ACTH level rises after estradiol application
(6). Furthermore, estradiol increases the presence of
PRL (21) and LH cells (11). It was demonstrated that
estrogen stimulates the hypothalamic production of
somatostatin (22), which was shown to decrease the
morphometric parameters of ACTH cells (14). Most
likely, an indirect mechanism of estradiol action, in -
volving somatostatin, is responsible for the changes in
ACTH cells observed in our study. In animals treated
with hCG the ACTH cell and nuclei volume were not
changed (p>0.05), but the volume density was signi f -
icantly decreased (p<0.05) by 23.1%, in comparison
with the controls. Considering the previously observed
hCG induced stimulation of pituitary FSH, LH and
TSH cells (11, 12), some potential compensatory inhi-
bition of ACTH cells, after hCG application in this
study, seems possible. 
In conclusion, our results indicate that neona -
tally injected EDP exerts a significant inhibitory effect
on the immunohistomorphometric characteristics of
ACTH cells in female rats, most likely due to indirect
mechanisms. After hCG application, an inhibitory
effect on the same characteristics of ACTH cells is not
as clearly expressed. 
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Figure 3. Cell volume (Vc; mm3) of ACTH cells; B. volume
of the nuclei (Vn; mm3) of ACTH cells; C. volume density
(VVC; %) of ACTH cells expressed as a percentage of total
gland tissue. All values are means ± standard deviation,
n = 5 animals per group, *p<0.05 vs. control.
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